Sanofi set to buy Bioverativ for more than $11.5 billion: WSJ
(Reuters) – Sanofi SA is close to a deal to take over U.S. drug maker Bioverativ Inc for more than $11.5 billion, the Wall Street Journal reported, citing people familiar with the matter.
Source:: https://finance.yahoo.com/news/sanofi-set-buy-bioverativ-more-11-5-billion-022212711–finance.html
